EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide

Yuji Tani iD, Shiro Makihara, Akihisa Morito, Manabu Ohyama iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.70062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Yuji Tani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Self-Medication Research Center, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan. Hauptthemen laut MEDLINE: Minoxidil, Alopecia, Hair Follicle, Hair. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taisho Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telogen effluvium (TE) refers to a transient hair loss condition due to the global and premature transition of scalp hair follicles from the anagen to the telogen phase of the hair cycle leading to excessive hair loss, which is triggered by a variety of physical/emotional stress, including severe infectious diseases. Because of its self‐healing nature, attempts to develop remedies for TE have rarely been conducted; still the demand for TE treatment exists as the condition can significantly impair the quality of life of affected individuals. This study aims to establish a mouse model of TE induced by lipopolysaccharide (LPS) and evaluate the therapeutic effects of topical minoxidil (tMXD), an established hair growth‐promoting medication. Mice had their dorsal hairs plucked to induce anagen transition and were administered LPS. LPS elicited a condition mimicking a cytokine storm with increases in interleukin‐6 levels and neutrophil counts. Accelerated transition of hair follicles into telogen was observed in LPS‐treated mice. Intriguingly, tMXD accelerated hair regrowth in LPS‐treated mice, resulting in earlier achievement of complete hair regrowth compared to controls. In aggregate, a previously unreported TE mouse model is established, and its use supports the ameliorative effect of tMXD on TE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MinoxidilAlopeciaHair FollicleHairAnimalsLipopolysaccharidesDisease Models, AnimalMiceFemaleInterleukin-6Administration, TopicalHumans

Stichwörter der Autor:innen

alopeciacytokineslipopolysaccharidesmiceminoxidil

Substanzen

MinoxidilLipopolysaccharidesInterleukin-6

Autor:innen und Institutionen

  • Pharmacology, Self-Medication Research Center, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.

ORCID-Profile: Yuji Tani, Manabu Ohyama

Förderung

  • Taisho Pharmaceutical Co., Ltd.
  • Taisho Toyama Pharmaceutical Company

Zitieren

APA

Tani, Y., Makihara, S., Morito, A., & Ohyama, M. (2025). Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70062

Vancouver

Tani Y, Makihara S, Morito A, Ohyama M. Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.70062

BibTeX
@article{Tani2025,
  author = {Tani, Yuji and Makihara, Shiro and Morito, Akihisa and Ohyama, Manabu},
  title = {Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.70062}
}
Kostenlos starten →